IGHE and Alzheimer disease: Pending confirmatory studies, the use of combined inflammatory indexes that also incorporate IgE concentrations might be particularly useful in the identification of late/non-responders to dupilumab who might benefit from alternative biologics or adapted dupilumab protocols for the management of AD.